- £166.96m
- £161.18m
- £41.93m
- 93
- 25
- 63
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 19.89 | ||
| PEG Ratio (f) | 1.71 | ||
| EPS Growth (f) | 13.18% | ||
| Dividend Yield (f) | 4.42% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.31 | ||
| Price to Tang. Book | 7.73 | ||
| Price to Free Cashflow | 21.5 | ||
| Price to Sales | 3.83 | ||
| EV to EBITDA | 16.16 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 19.59% | ||
| Return on Equity | 19.61% | ||
| Operating Margin | 16.64% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 31.68 | 27.24 | 31.12 | 36.01 | 41.93 | 46.27 | 51.16 | 9.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +22.31 | -69.15 | +59.92 | +78.35 | +41.4 | +17.05 | +12.37 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Tristel plc is a United Kingdom-based manufacturer of infection prevention products. The Company's core business is the sale to hospitals of its chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. The Company operates through three segments: Hospital medical device decontamination, Hospital environmental surface disinfection and others. It manufactures and sells medical device decontamination products which are used primarily for infection control in hospitals. The Company also manufactures and sells hospital environmental surface disinfection products. The Company is also focused on pharmaceutical and personal care product manufacturing industries, veterinary and animal welfare sectors. The Tristel brand offers airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal (GI) physiology, laboratory, ophthalmology, and ultrasound.
Directors
- Bruno Holthof NEC
- Paul Swinney CEO (61)
- Elizabeth Dixon CFO (49)
- Bart Leemans EDR
- David Orr NED (62)
- Tom Jenkins NID
- Isabel Napper NID (63)
- Caroline Stephens NID
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 9th, 2003
- Public Since
- June 1st, 2005
- No. of Employees
- 238
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
London Stock Exchange- Shares in Issue
- 47,702,343
- Address
- Lynx Business Park,Fordham Road, SNAILWELL, CB8 7NY
- Web
- https://tristel.com/hk-en/
- Phone
- +44 1638721500
- Auditors
- Grant Thornton LLP
Latest News for TSTL
Upcoming Events for TSTL
Full Year 2025 Tristel PLC Earnings Release
Similar to TSTL
Abingdon Health
London Stock Exchange
Advanced Medical Solutions
London Stock Exchange
Angle
London Stock Exchange
Aoti
London Stock Exchange
Aptamer
London Stock Exchange
FAQ
As of Today at 23:47 UTC, shares in Tristel are trading at 350.00p. This share price information is delayed by 15 minutes.
Shares in Tristel last closed at 350.00p and the price had moved by -24.73% over the past 365 days. In terms of relative price strength the Tristel share price has underperformed the FTSE All Share Index by -27.69% over the past year.
The overall consensus recommendation for Tristel is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Tristel dividend yield is 3.99% based on the trailing twelve month period.
Last year, Tristel paid a total dividend of £0.14, and it currently has a trailing dividend yield of 3.99%. We do not have any data on when Tristel is to next pay dividends.
We do not have data on when Tristel is to next pay dividends. The historic dividend yield on Tristel shares is currently 3.99%.
To buy shares in Tristel you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 350.00p, shares in Tristel had a market capitalisation of £166.96m.
Here are the trading details for Tristel:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: TSTL
Based on an overall assessment of its quality, value and momentum Tristel is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Tristel is 445.60p. That is 27.31% above the last closing price of 350.00p.
Analysts covering Tristel currently have a consensus Earnings Per Share (EPS) forecast of £0.16 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Tristel. Over the past six months, its share price has underperformed the FTSE All Share Index by -9.97%.
As of the last closing price of 350.00p, shares in Tristel were trading -12.46% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Tristel PE ratio based on its reported earnings over the past 12 months is 19.89. The shares last closed at 350.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Tristel's management team is headed by:
- Bruno Holthof - NEC
- Paul Swinney - CEO
- Elizabeth Dixon - CFO
- Bart Leemans - EDR
- David Orr - NED
- Tom Jenkins - NID
- Isabel Napper - NID
- Caroline Stephens - NID